Pacific Biosciences of California, Inc. (PACB): Price and Financial Metrics
PACB Price/Volume Stats
| Current price | $1.55 | 52-week high | $14.55 |
| Prev. close | $1.46 | 52-week low | $1.25 |
| Day low | $1.43 | Volume | 16,879,700 |
| Day high | $1.67 | Avg. volume | 9,842,573 |
| 50-day MA | $4.23 | Dividend yield | N/A |
| 200-day MA | $8.05 | Market Cap | 415.33M |
PACB Stock Price Chart Interactive Chart >
Pacific Biosciences of California, Inc. (PACB) Company Bio
Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company was formerly known as Nanofluidics, Inc. The company was founded in 2000 and is based in Menlo Park, California.
Latest PACB News From Around the Web
Below are the latest news stories about PACIFIC BIOSCIENCES OF CALIFORNIA INC that investors may wish to consider to help them evaluate PACB as an investment opportunity.
PacBio to Present at 42nd Annual J.P. Morgan Healthcare ConferencePacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenting at the 42nd Annual J.P. Morgan Healthcare Conference on Wednesday, January 10, 2024, at 1:30 PM PT (4:30 PM ET) in San Francisco, California. |
CVRx (CVRX) Moves 24.2% Higher: Will This Strength Last?CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term. |
Reasons to Retain PacBio (PACB) Stock in Your Portfolio NowPacBio's (PACB) product development activities raise optimism about the stock. |
12 Most Promising Gene Editing Stocks According to Hedge FundsIn this piece, we will take a look at the 12 most promising gene editing stocks according to hedge funds. If you want to skip our take on how the gene editing industry sits right at the top of the global innovation food chain, then you can take a look at the 5 Most Promising […] |
Investors in Pacific Biosciences of California (NASDAQ:PACB) have unfortunately lost 60% over the last three yearsPacific Biosciences of California, Inc. ( NASDAQ:PACB ) shareholders should be happy to see the share price up 29% in... |
PACB Price Returns
| 1-mo | -59.64% |
| 3-mo | -76.48% |
| 6-mo | -78.65% |
| 1-year | -85.92% |
| 3-year | -94.87% |
| 5-year | -78.80% |
| YTD | -84.20% |
| 2023 | 19.93% |
| 2022 | -60.02% |
| 2021 | -21.13% |
| 2020 | 404.67% |
| 2019 | -30.54% |
Continue Researching PACB
Want to see what other sources are saying about Pacific Biosciences Of California Inc's financials and stock price? Try the links below:Pacific Biosciences Of California Inc (PACB) Stock Price | Nasdaq
Pacific Biosciences Of California Inc (PACB) Stock Quote, History and News - Yahoo Finance
Pacific Biosciences Of California Inc (PACB) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...